Global Biochips Sales Market Report 2020
Biochips are bio-microsystems. Bio-microsystems are small integrated devices used for biochemical reactions, biological monitoring, research, academic studies, drug discovery, and much more. In simple terms, biochips are small sized chips that can perform multiple (generally thousands) biochemical reactions parallelly. A collection of microarrays or micro-test sites form these biochips. Microarrays when arranged on a surface made up of either glass or silicon, can perform large numbers of tests at the same. Thus, they help in cost and time saving.
North America accounted for the largest share of the biochips market in 2017. The large share of this regional segment can majorly be attributed to the rising geriatric population; increasing prevalence of lifestyle diseases, such as diabetes, asthma, and cardiac disorders; growing adoption of biochips; and a significant number of ongoing research activities and discoveries related to biochips in the North American region. In addition, major local companies have easy access to Biochips market, which makes it the largest and most significant market for suppliers. Asia-Pacific, on the other hand, is expected to grow at the highest CAGR over the next five years.
Market Analysis and Insights: Global Biochips Market
The global Biochips market size is projected to reach US$ 16490 million by 2026, from US$ 9796.3 million in 2020, at a CAGR of 9.1% during 2021-2026.
Global Biochips Scope and Market Size
The global Biochips market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biochips market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Biochips market is segmented into
DNA Chip
Lab-on-a-Chip
Protein Chip
Others
Segment by Application, the Biochips market is segmented into
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Other End Users
The Biochips market is analysed and market size information is provided by regions (countries). Segment by Application, the Biochips market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Biochips market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biochips business, the date to enter into the Biochips market, Biochips product introduction, recent developments, etc.
The major vendors covered:
Abbott
Agilent Technologies
Illumina
PerkinElmer
Thermo Fisher Scientific
BioChain
Bio-Rad Laboratories
Cepheid
EMD Millipore
Fluidigm
SuperBioChips Laboratories
US Biomax
Roche Diagnostics
North America accounted for the largest share of the biochips market in 2017. The large share of this regional segment can majorly be attributed to the rising geriatric population; increasing prevalence of lifestyle diseases, such as diabetes, asthma, and cardiac disorders; growing adoption of biochips; and a significant number of ongoing research activities and discoveries related to biochips in the North American region. In addition, major local companies have easy access to Biochips market, which makes it the largest and most significant market for suppliers. Asia-Pacific, on the other hand, is expected to grow at the highest CAGR over the next five years.
Market Analysis and Insights: Global Biochips Market
The global Biochips market size is projected to reach US$ 16490 million by 2026, from US$ 9796.3 million in 2020, at a CAGR of 9.1% during 2021-2026.
Global Biochips Scope and Market Size
The global Biochips market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biochips market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Biochips market is segmented into
DNA Chip
Lab-on-a-Chip
Protein Chip
Others
Segment by Application, the Biochips market is segmented into
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Other End Users
The Biochips market is analysed and market size information is provided by regions (countries). Segment by Application, the Biochips market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape
and Biochips Market Share AnalysisBiochips market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biochips business, the date to enter into the Biochips market, Biochips product introduction, recent developments, etc.
The major vendors covered:
Abbott
Agilent Technologies
Illumina
PerkinElmer
Thermo Fisher Scientific
BioChain
Bio-Rad Laboratories
Cepheid
EMD Millipore
Fluidigm
SuperBioChips Laboratories
US Biomax
Roche Diagnostics
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
